Sort
51,593 grants matching “hepatitis”
Vascular remodeling in patients with rare genetic disorders
$1,826,325Manfred Boehm · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
The Ohio State University AIDS Clinical Trials Unit
$1,825,977Susan L Koletar · Ohio State University · U01 · FY2007 · AI
ADULT AIDS CLINICAL TRIALS UNIT
$1,824,091Washington University · U01 · FY2004 · AI
B Cell Epitope Discovery: Dengue, Hepatitis C, Ebola, and Chikungunya viruses
$1,823,674Benjamin Jacob Doranz · Integral Molecular · N01 · FY2011 · AI
Primary Immuno-Deficiencies Affecting Specific Stages of the Immune Response
$1,822,109Cornelis P Terhorst · Beth Israel Deaconess Medical Center · P01 · FY2009 · AI
AIDS CLINICAL TRIALS GROUP - ACTU
$1,821,879University Of Cincinnati · U01 · FY2003 · AI
A 3D biomimetic liver sinusoid construct for predicting physiology and toxicity
$1,821,017D. Lansing Taylor · University Of Pittsburgh At Pittsburgh · UH3 · FY2016 · TR
Functional Genomics and HCV-Associated Liver Disease
$1,820,909University Of Washington · P30 · FY2003 · DA
Host-pathogen competition in IFN mediated antiviral defense
$1,820,077Jae U Jung · University Of Southern California · U19 · FY2013 · AI
Clinical Genomics and Experimental Therapeutics
$1,819,272Falk Lohoff · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2022 · AA
Functional Genomics and HCV-Associated Liver Disease
$1,819,228Michael G Katze · University Of Washington · P30 · FY2009 · DA
Tortuous vascular accessibility with a novel coaxial active deflectable microcatheter
$1,818,904Stephen Tully · Agile Devices, Inc. · R44 · FY2018 · HL
Trial to Assess Chelation Therapy (TACT)
$1,816,603Gervasio A Lamas · Mount Sinai Medical Center (Miami Beach) · U01 · FY2012 · HL
Case Clinical Trials Unit
$1,815,053Benigno Rodriguez · Case Western Reserve University · UM1 · FY2018 · AI
Immunology of Acute and Chronic Viral Hepatitis
$1,814,404Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Caribbean, Central and South America Network for HIV Epidemiology (CCASAnet)
$1,813,893Catherine C McGowan · Vanderbilt University Medical Center · U01 · FY2019 · AI
Nonalcoholic Steatohepatitis: Natural History, Pathogenesis and Therapy
$1,813,730Yaron Rotman · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
ADULT AIDS CLINICAL TRIALS UNIT (AACTU)
$1,813,503University Of Rochester · U01 · FY2000 · AI
AIDS CLINICAL TRIALS GROUP - ACTU
$1,812,695University Of Cincinnati · U01 · FY2004 · AI
GENETICS OF ATHEROSCLEROSIS--ROLE OF INSULIN RESISTANCE
$1,811,199University Of California Los Angeles · P01 · FY2002 · HL
Discovery of an Orexin-1 receptor antagonist for treatment of cocaine addiction and dependence
$1,808,268Robert Cooke · Heptares Therapeutics, Ltd · R01 · FY2017 · DA
Descriptive Studies and Record Linkage
$1,804,510William Anderson · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA
Metabolic Control Analysis
$1,804,470Richard L Veech · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2019 · AA
Functional Genomics and HCV-Associated Liver Disease
$1,803,951University Of Washington · P30 · FY2002 · DA
New therapies for liver fibrosis and hyperproliferation in alpha1-AT deficiency
$1,803,138David H Perlmutter · University Of Pittsburgh At Pittsburgh · P01 · FY2015 · DK